TRIB3 plays an important role in fibroblast activation in systemic sclerosis (SSc) by activating the canonical TGF-β/SMAD signaling pathway and stimulating the release of collagen, thereby inducing a positive feedback loop that may contribute to aberrant TGF-β signaling in SSc24. Here, TRIB3 is linked to systemic sclerosis.